BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15170979)

  • 21. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
    Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
    Tashiro H; Nomura Y; Ohsaki A
    Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A controlled study with medroxyprogesterone acetate (MPA) alone or in combination with cyclophosphamide (CPA) in the treatment of advanced or recurrent breast cancer unresponsive to other therapies. Osaka Study Group for the Treatment of Breast Cancer].
    Aikawa T; Yayoi E; Takatsuka Y; Maeura Y; Miyauchi K
    Gan To Kagaku Ryoho; 1991 May; 18(6):995-1002. PubMed ID: 1827575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
    Taguchi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1295-301. PubMed ID: 2114825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
    Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
    Wada N; Kobayashi H; Oka S; Ando J; Tamura H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical trial of UFT against disseminated breast cancer].
    Itoh S; Konishi Y; Harauchi D; Shinoto M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2381-5. PubMed ID: 6437344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
    Iguchi C; Nio Y; Sato Y; Watanabe H; Ohishi T; Abe M; Yano S; Sumi S; Tamura K
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1641-5. PubMed ID: 10553424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of UFT activity in pretreated breast cancer patients.
    Daniels M; Díaz-Rubio E; Guillem V; Montero JM; García-Conde J; Estapé J; Martín M; Herranz C; Ordoñez A; Galán A
    Jpn J Clin Oncol; 1993 Dec; 23(6):363-5. PubMed ID: 8283790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
    Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
    Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
    Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
    J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
    Akiyama J; Sagara Y; Takeda Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative, randomized trial of UFT and 5-fluorouracil in combination with cyclophosphamide and doxorubicin in the treatment of advanced breast cancer patients at The Philippines General Hospital.
    Villalon AH; De Guzman LM; Samson MC; Guancia AA; Fernando GY; Romana IB
    Oncology; 1997; 54 Suppl 1():2-6. PubMed ID: 8978577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical trial of UFT in recurrent or advanced cancer].
    Kunitomo K; Kuwashima T; Korematsu H; Tamura T; Yoshikawa H; Toyosaki M; Komi N
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):72-8. PubMed ID: 6820878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
    Uehara T; Yano T; Kanematsu T; Terazaki Y; Kuninaka S; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):137-9. PubMed ID: 9987510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
    Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.